Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Oncogenesis
SJR: 0.946 SNIP: 0.503 CiteScore™: 2

ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v20.i5-6.150
pages 449-473

Drug Development for Metastasis Prevention

Yari Fontebasso
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
Steven M. Dubinett
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

SINOPSIS

Metastatic disease is responsible for 90% of death from solid tumors. However, only a minority of metastasis-specific targets has been exploited therapeutically, and effective prevention and suppression of metastatic disease is still an elusive goal. In this review, we will first summarize the current state of knowledge about the molecular features of the disease, with particular focus on steps and targets potentially amenable to therapeutic intervention. We will then discuss the reasons underlying the paucity of metastatic drugs in the current oncological arsenal and potential ways to overcome this therapeutic gap. We reason that the discovery of novel promising targets, an increased understanding of the molecular features of the disease, the effect of disruptive technologies, and a shift in the current preclinical and clinical settings have the potential to create more successful drug development endeavors.


Articles with similar content:

Ductal Carcinoma In Situ: A Brief Review of Treatment Variation and Impacts on Patients and Society
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 4
Ted James , Phil Brown, Jane Kolodinsky, Marie Wood, Christine Vatovec, Mujde Z. Erten, Brian L. Sprague
Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
Elizabeth R. Lawlor, Poul H. Sorensen
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
James J. Morrow, Chand Khanna
Drugs That Target Gene Expression: An Overview
Critical Reviews™ in Eukaryotic Gene Expression, Vol.6, 1996, issue 1
Filippo Cavalieri
Approaches for Skeletal Gene Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 3
Paul D. Robbins, Christopher Niyibizi, Corey J. Wallach, Zhibao Mi